BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 25, 2018
View Archived Issues
Nohla Therapeutics' NLA-101 receives orphan drug designation in E.U.
Read More
NIAID awards SBIR grant to support preclinical development of NovoBiotic's NOVO-29
Read More
Apexian Pharmaceuticals initiates phase I trial of APX-3330 in patients with solid tumors
Read More
FDA clears IND application for VY-AADC pivotal program in advanced Parkinson's disease
Read More
Anti-RGMA ameliorates symptoms of neuromyelitis optica
Read More
Santhera anticipates negative CHMP opinion on appeal for MAA for Raxone
Read More
IntelGenx studying Montelukast Versafilm in proof-of-concept trial in Alzheimer's
Read More
Activity seen with anti-PD-1 antibody JS-001 in advanced gastric adenocarcinoma
Read More
PF-05280586 demonstrates equivalence to MabThera in clinical trial
Read More
European Commission grants orphan drug designation to sirolimus for sickle cell disease
Read More
Treos Bio cleared by FDA to conduct phase I study of PolyPEPI-1018
Read More
Achieve Life Sciences amends technology license agreement with University of Bristol
Read More
TrovaGene begins phase II study of PCM-075 in mCRPC
Read More
M-7824 shows potential as therapy for heavily pretreated CRC patients
Read More
First pivotal trial of F-627 to treat chemotherapy-induced neutropenia meets primary endpoint
Read More
Iovance reports preliminary phase II data on autologous TIL therapy LN-145
Read More
Spark licenses voretigene neparvovec to Novartis outside U.S.
Read More
Translate Bio divulges mRNA compositions encoding ornithine transcarbamylase
Read More
Varian Medical Systems patents novel immune modulators
Read More
Genetically modified HUCPVCs created at Tissue Regeneration Therapeutics
Read More
Nitto Denko identifies novel inhibitors of GST class-pi and MRP-L17
Read More
Shanghai Institute of Cell Therapy and collaborators patent novel transgenic killer cells
Read More
Luye Pharma reports positive phase II results for LY-03005
Read More
Conditional approval for Vaccibody's CTA for phase I/II trial of VB10.NEO
Read More
European Commission grants approval to Taltz for active psoriatic arthritis
Read More
Synpromics collaborates with UCL to develop gene therapies for blood-based disorders
Read More
ACTR-087 studied in combination with SEA-BCMA in multiple myeloma
Read More